JD Supra11d
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Phys.org29d
Drug candidates target metabolic pathway in bacteria while sparing human cells
This principle is an important basis for the development of antibiotics ... If the MEP pathway in bacteria is blocked, for example by a drug, the bacteria can no longer produce a number of ...
Morningstar14d
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
Extending their collaboration, Genialis and Debiopharm continue working towards a patient classifier to support WEE1 clinical development ... landscape of cancer drug targets, including DDR.
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional significant funding from the National ...
Business Wire13d
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
DDR is a promising arena for the development of precision medicines ... of biomarkers across the entire landscape of cancer drug targets, including DDR. Trained on hundreds of thousands of ...
Sydney Morning Herald5d
A small team of Australian scientists won a rare drug approval – and upended the pharma system
independent team of Australian scientists won a rare approval – upending the normal drug development pathway. The success of their audacious strategy paves the way for charities and not-for ...
Precise binding free energy calculations unlock new frontiers in drug design
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
Ocean Biomedical, Inc.: Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional ...